Hippocampal endosomal, lysosomal, and autophagic dysregulation in mild cognitive impairment: correlation with aβ and tau pathology

Journal of Neuropathology and Experimental Neurology
S E PerezE J Mufson

Abstract

Endosomal-lysosomal and autophagic dysregulation occurs in the hippocampus in prodromal Alzheimer disease (AD), but its relationship with β-amyloid (Aβ) and tau pathology remains unclear. To investigate this issue, we performed immunoblot analysis of hippocampal homogenates from cases with an antemortem clinical diagnosis of no cognitive impairment, mild cognitive impairment (MCI), and AD. Western blot analysis revealed significant increases in the acid hydrolase cathepsin D and early endosome marker rabaptin5 in the MCI group compared with AD, whereas levels of phosphorylated mammalian target of rapamycin proteins (pmTOR), total mammalian target of rapamycin (mTOR), p62, traf6, and LilrB2 were comparable across clinical groups. Hippocampal Aβ1-40 and Aβ1-42 concentrations and AT8-immunopositive neurofibrillary tangle density were not significantly different across the clinical groups. Greater cathepsin D expression was associated with global cognitive score and episodic memory score but not with mini mental state examination or advanced neuropathology criteria. These results indicate that alterations in hippocampal endosomal-lysosomal proteins in MCI are independent of tau or Aβ pathology.

References

May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A M Cataldo, R A Nixon
Feb 15, 1992·Experientia·P O Seglen, P Bohley
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Dec 6, 1985·Science·J W GeddesH C Chui
Jul 23, 1999·Experimental Neurology·E J MufsonJ H Kordower
Nov 24, 1999·Journal of Neuropathology and Experimental Neurology·K L NewellE T Hedley-Whyte
Sep 28, 2000·Cell·C A Joazeiro, A M Weissman
Mar 2, 2002·Journal of Biochemistry·Yoko ShibaKazuhisa Nakayama
Jun 13, 2002·Neuropathology and Applied Neurobiology·E KuusistoI Alafuzoff
Feb 19, 2003·Journal of Alzheimer's Disease : JAD·Milos D IkonomovicSteven T DeKosky
Dec 4, 2003·Neurobiology of Aging·Stephen W Scheff, Douglas A Price
Jun 26, 2004·Journal of Neuropathology and Experimental Neurology·Shiyong PengMargaret Fahnestock
Jun 15, 2005·Journal of Neurochemistry·Jeganathan Ramesh BabuMarie W Wooten
Feb 14, 2006·Cell·Stephan WullschlegerMichael N Hall
Feb 3, 2007·Molecular Biology of the Cell·Jay LiuGuangpu Li
May 22, 2007·Developmental Neurobiology·Francisca C BronfmanAlex Kruttgen
Jul 6, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Daphna LaifenfeldRachael L Neve
Feb 26, 2008·The European Journal of Neuroscience·Tadanori HamanoLi-wen Ko
Mar 15, 2008·Brain : a Journal of Neurology·Milos D IkonomovicSteven T DeKosky
Mar 19, 2008·Journal of Neurochemistry·J Ramesh BabuMarie W Wooten
May 13, 2008·Molecular and Cellular Neurosciences·Ruifeng CaoKarl Obrietan
May 20, 2008·Brain Research Reviews·Ee Ling Ng, Bor Luen Tang
Jul 25, 2008·The Journal of Biological Chemistry·Gopal Thinakaran, Edward H Koo
Dec 17, 2008·Free Radical Biology & Medicine·Yifeng DuMarie W Wooten
Mar 7, 2009·The American Journal of Pathology·Jeroen J M HoozemansWiep Scheper
Mar 10, 2009·Autophagy·Shih-Ya HungWen-Mei Fu

❮ Previous
Next ❯

Citations

Apr 14, 2017·Frontiers in Aging Neuroscience·Nady BraidyPerminder S Sachdev
Mar 11, 2017·Neuron·Fiona M MenziesDavid C Rubinsztein
Nov 3, 2016·Expert Opinion on Therapeutic Targets·Fabio Di DomenicoMarzia Perluigi
Jan 21, 2019·Molecular Neurobiology·A Raquel EstevesSandra M Cardoso
Aug 31, 2016·Molecular Psychiatry·A CaccamoS Oddo
Oct 5, 2017·Journal of Bioenergetics and Biomembranes·Haiying LiuWenting Wang
Feb 15, 2018·Journal of Alzheimer's Disease : JAD·Laura MahadyElliott J Mufson
Jun 12, 2018·BioMed Research International·Louise O'Keefe, Donna Denton
Aug 15, 2020·Frontiers in Psychiatry·Christine NiemeyerNils C Gassen
Jun 20, 2017·Frontiers in Aging Neuroscience·Mai A ShafeiMyra E Conway
Apr 9, 2019·Journal of Alzheimer's Disease : JAD·Maja MustapicDimitrios Kapogiannis
Jan 15, 2020·Current Neuropharmacology·Yuan ZhaoGuofeng Yang
Apr 22, 2021·Metabolic Brain Disease·Shereen Shi Min LaiSoi Moi Chye
Jul 3, 2021·Molecular Neurobiology·Tarapati RanaSimona Bungau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Endosomes

Dysfunctional endosomal trafficking may be associated with Alzheimer’s disease (AD) pathology. Targeting the endosome may advance treatment options for AD. Here is the latest research on endosomes and AD.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.